Graf Akcie EKSO (Ekso Bionics Holdings Inc). Diskuze k akciím EKSO. Aktuální informace EKSO.

Základní informace o společnosti Ekso Bionics Holdings Inc (Akcie EKSO)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 53.02M
Hodnota podniku (EV) N/A
Tržby 9.272M
EBITDA N/A
Zisk -6.47
Růst v tržbách Q/Q -2.34 %
Růst v tržbách Y/Y -13.92 %
P/E (Cena vůči ziskům) 0.00
Forward P/E -0.40
EV/Sales 1.54
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 5.72
P/FCF N/A
Price/Book 11.96
Účetní hodnota na akcii 0.35
Hotovost na akcii 1.01
FCF vůči ceně -16.25 %
Počet zaměstnanců 40
Tržba na zaměstnance 231.800k
Profit margin -178.17 %
Operating margin -128.40 %
Gross margin 57.08 %
EBIT margin -68.65 %
EBITDA margin -154.11 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst -89.89 %
EPS - Očekávaný růst příští rok -183.33 %
Return on assets -16.85 %
Return on equity -27.55 %
ROIC -73.80 %
ROCE -13.18 %
Dluhy/Equity 3.65
Čistý dluh/EBITDA 2.03
Current ratio 10.96
Quick Ratio 10.54
Volatilita 5.66
Beta 1.40
RSI 41.28
Cílová cena analytiků 11
Známka akcie (dle analytiků) 1.00
Insider ownership 3.23 %
Institutional ownership 16.95 %
Počet akcií 12.655M
Procento shortovaných akcií 2.16 %
Short ratio 3.55 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2015
Země United States

Finanční výsledky akcie EKSO

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$13.917$11.332$7.353$14.221$8.661$5.327
Cost Of Goods Sold$7.153$7.023$5.284$11.274$7.482$3.768
Gross Profit$6.764$4.309$2.069$2.947$1.179$1.559
Research And Development Expenses$4.596$5.847$9.483$8.879$6.48$3.868
SG&A Expenses$18.807$25.492$23.871$21.85$16.26$14.485
Other Operating Income Or Expenses--$0.332$0.196--
Operating Expenses$30.556$38.362$38.965$41.807$30.222$22.121
Operating Income$-16.639$-27.03$-31.612$-27.586$-21.561$-16.794
Total Non-Operating Income/Expense$4.507$0.038$2.49$4.116$1.971$-16.975
Pre-Tax Income$-12.132$-26.992$-29.122$-23.47$-19.59$-33.769
Income Taxes------
Income After Taxes$-12.132$-26.992$-29.122$-23.47$-19.59$-33.769
Other Income------
Income From Continuous Operations$-12.132$-26.992$-29.122$-23.47$-19.59$-33.769
Income From Discontinued Operations------
Net Income$-12.132$-26.992$-29.122$-33.815$-24.245$-33.769
EBITDA$-15.857$-25.363$-29.685$-25.767$-20.665$-15.877
EBIT$-16.639$-27.03$-31.612$-27.586$-21.561$-16.794
Basic Shares Outstanding542111
Shares Outstanding542111
Basic EPS$-2.55$-6.60$-12.29$-28.04$-24.89$-45.28
EPS - Earnings Per Share$-2.55$-6.60$-12.29$-30.73$-27.44$-45.28
# 2020 2019 2018 2017 2016 2015
Current Ratio2.40131.48483.8123.26812.92394.43
Long-term Debt / Capital0.05650.49260.18420.5097--
Debt/Equity Ratio0.40311.82590.32581.03950.00910.0018
Gross Margin48.602438.025128.138220.722913.612829.266
Operating Margin-119.5588-238.5281-429.9198-193.9807-248.9435-315.2619
EBIT Margin-119.5588-238.5281-429.9198-193.9807-248.9435-315.2619
EBITDA Margin-113.9398-223.8175-403.7127-181.1898-238.5983-298.0477
Pre-Tax Profit Margin-87.174-238.1927-396.056-165.0376-226.1863-633.9215
Net Profit Margin-87.174-238.1927-396.056-237.7822-279.933-633.9215
Asset Turnover0.6350.64190.19360.58220.2690.1591
Inventory Turnover Ratio2.87382.08341.74687.24557.08526.0579
Receiveable Turnover2.67223.09622.66417.98934.18613.439
Days Sales In Receivables136.5898117.8874137.005345.68687.1937106.1357
ROE - Return On Equity-178.4903-989.4402-136.1414-359.3629-222.4115-148.1097
Return On Tangible Equity-183.5956-1063.095-140.6113-441.4974-278.4647-148.4678
ROA - Return On Assets-55.3593-152.8859-76.6611-96.0901-60.8423-100.8813
ROI - Return On Investment-168.4064-502.0833-111.0636-176.2012-222.4115-148.1097
Book Value Per Share1.17240.64965.35024.47238.787823.5555
Operating Cash Flow Per Share2.1397.71986.9779-1.37641.374225.2374
Free Cash Flow Per Share2.15867.87977.6683-0.72761.836925.1404